Precision BioSciences Inc. Form 8-K Summary
Business Context and Reporting Period
Precision BioSciences Inc. (DTIL), a Delaware corporation, filed this Current Report on Form 8-K on January 15, 2020. The company is an emerging growth company and its common stock trades on the Nasdaq Global Select Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a regulatory disclosure regarding a corporate event rather than a financial report.
Material Changes
No material financial changes or operational updates are reported in this filing. The report solely announces a scheduled presentation at an industry conference.
Guidance, Outlook, and Management Commentary
The company announced it will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on January 15, 2020. A live webcast link and presentation materials were made available on the company's Investor & Media website. A replay of the webcast was to be archived for 30 days following the event.
Investor Verification Checklist
- Verify the availability of the archived webcast replay on the company's investor relations website.
- Review the presentation materials discussed at the J.P. Morgan Healthcare Conference for updated business outlook or pipeline data.
- Confirm the company's status as an emerging growth company and any associated reporting exemptions.